Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer?
Boccardo
F
F
Miglietta
L
L
Bruzzone
M
M
Rubagotti
A
A
Locatelli
M C
MC
Ragni
N
N
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D017410:Practice Guidelines as Topic
D000972:Antineoplastic Agents, Phytogenic; D009944:Organoplatinum Compounds; D017239:Paclitaxel; D002945:Cisplatin